894
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Modified translationally controlled tumor protein-derived protein transduction domain enhances nasal delivery of exendin-4 as shown with insulin

, , &
Pages 1579-1584 | Received 15 May 2018, Accepted 18 Jun 2018, Published online: 25 Jul 2018

References

  • Bae HD, Lee J, Jun KY, et al. (2018). Modification of translationally controlled tumor protein-derived protein transduction domain for improved intranasal delivery of insulin. Drug Deliv 25:1025–32.
  • Bae HD, Lee K. (2013). On employing a translationally controlled tumor protein-derived protein transduction domain analog for transmucosal delivery of drugs. J Control Release 170:358–64.
  • Battaglia L, Panciani PP, Muntoni E, et al. (2018). Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery. Expert Opin Drug Deliv 15:369–78.
  • Bolhassani A, Jafarzade BS, Mardani G. (2017). In vitro and in vivo delivery of therapeutic proteins using cell penetrating peptides. Peptides 87:50–63.
  • Chien YW, Chang SF. (1987). Intranasal drug delivery for systemic medications. Crit Rev Ther Drug Carrier Syst 4:67–194.
  • Davis SS, Illum L. (2003). Absorption enhancers for nasal drug delivery. Clin Pharmacokinet 42:1107–28.
  • Gros E, Deshayes S, Morris MC, et al. (2006). A non-covalent peptide-based strategy for protein and peptide nucleic acid transduction. Biochim Biophys Acta 1758:384–93.
  • Jiang Y, Li M, Zhang Z, et al. (2014). Cell-penetrating peptides as delivery enhancers for vaccine. Curr Pharm Biotechnol 15:256–66.
  • Khafagy El S, Morishita M, Takayama K. (2010). The role of intermolecular interactions with penetratin and its analogue on the enhancement of absorption of nasal therapeutic peptides. Int J Pharm 388:209–12.
  • Kim M, Kim M, Kim HY, et al. (2011a). A protein transduction domain located at the NH2-terminus of human translationally controlled tumor protein for delivery of active molecules to cells. Biomaterials 32:222–30.
  • Kim M, Maeng J, Jung J, et al. (2011b). Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein. Eur J Pharm Sci 43:25–31.
  • Kristensen M, De Groot AM, Berthelsen J, et al. (2015). Conjugation of cell-penetrating peptides to parathyroid hormone affects its structure, potency, and transepithelial permeation. Bioconjugate Chem 26:477–88.
  • Maiolo JR, Ferrer M, Ottinger EA. (2005). Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides. Biochim Biophys Acta 1712:161–72.